![]() |
|
![]() |
| Home | About and More Information | Transporter Data Index |
No substrate information.
No inhibitor information.
| DDI | Implicated Transporter* | Interacting Drug | Affected Drug | AUC | Cmax | CLR | CL/F | t1/2 | Effect on PD | Reference | More Details |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical PK Impact(fold change) | |||||||||||
| 1 | ABCB1/ABCG2/OATP1B1/OATP1B3 | Cyclosporine | Voxilaprevir | 9.73 | 14.29 | ND | ND | ND | ND | Yu, 2019 | DDI 1 |
| 2 | OATP1B1/OATP1B3 | Rifampicin | Voxilaprevir | 7.96 | 8.74 | ND | ND | ND | ND | Yu, 2019 | DDI 2 |
| 3 | ABCG2/OATP1B1/OATP1B3 | Voxilaprevir | Rosuvastatin | 7.35 | 17.96 | ND | ND | ND | ND | Yu, 2019 | DDI 3 |
PK = pharmacokinetic
The transporters are implicated by in vitro data and/or studies in humans with genetic polymorphisms of the transporter
DDI = Drug Drug Interaction
PD = pharmacodynamic
ND = not determined
NS = not significant
N/A = information not available
Calculation of Fold Change: fold change in the presence of the interacting drug = (value with interacting drug)/(value without interacting drug)
fold change > 1: increase in pharmacokinetic value
fold change < 1: decrease in pharmacokinetic value